Spyre Therapeutics (SYRE) Current Leases (2019 - 2023)
Spyre Therapeutics (SYRE) reported Current Leases of $4.3 million for Q2 2023, up 807.97% on a YoY basis from $477000.0 in Q2 2022, and up 612.34% quarter-over-quarter from $608000.0 in Q1 2023.
Spyre Therapeutics (SYRE) Current Leases (2019 - 2023) Analysis & Trends
Spyre Therapeutics has reported Current Leases for 5 years, with the latest figure at $4.3 million in Q2 2023.
- For the quarter ending Q2 2023, Current Leases rose 807.97% year-over-year to $4.3 million; the trailing twelve-month figure through Jun 2023 stood at $4.3 million (up 807.97% YoY), and the FY2022 full-year result was $625000.0, up 43.35% from the prior year.
- Current Leases for Q2 2023 stood at $4.3 million, up from $608000.0 in the prior quarter.
- The five-year high for Current Leases was $4.3 million in Q2 2023, with the low at $228000.0 in Q2 2020.
- Historically, Current Leases has averaged $618277.8 across 5 years, with a median of $381500.0 in 2019.
- Annual changes were most pronounced in 2020 — Current Leases slumped 30.49% — and 2023, when it surged 807.97%.
- Spyre Therapeutics' Current Leases stood at $351000.0 in 2019, then slipped by 9.12% to $319000.0 in 2020, then soared by 36.68% to $436000.0 in 2021, then jumped by 43.35% to $625000.0 in 2022, then soared by 592.96% to $4.3 million in 2023.
- The last three Current Leases figures came in at $4.3 million (Q2 2023), $608000.0 (Q1 2023), and $625000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Spyre Therapeutics | 6.95 Bn | 6.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4.33 Mn |
| Mar 31, 2023 | 608,000.00 |
| Dec 31, 2022 | 625,000.00 |
| Sep 30, 2022 | 587,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Mar 31, 2022 | 457,000.00 |
| Dec 31, 2021 | 436,000.00 |
| Sep 30, 2021 | 415,000.00 |
| Jun 30, 2021 | 412,000.00 |
| Mar 31, 2021 | 315,000.00 |
| Dec 31, 2020 | 319,000.00 |
| Sep 30, 2020 | 341,000.00 |
| Jun 30, 2020 | 228,000.00 |
| Mar 31, 2020 | 293,000.00 |
| Dec 31, 2019 | 351,000.00 |
| Sep 30, 2019 | 289,000.00 |
| Jun 30, 2019 | 328,000.00 |
| Mar 31, 2019 | 317,000.00 |